Davidson Capital Management Inc. Bristol Myers Squibb CO Transaction History

Davidson Capital Management Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 17, 2022	SELL	$72.62 - $79.98 $1.71 Million - $1.89 Million	-23,600 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$61.48 - $73.72 $560,943 - $672,621	9,124 Added 63.03%	23,600 $1.72 Million
Q4 2021 Feb 02, 2022	SELL	$53.63 - $62.52 $260,159 - $303,284	-4,851 Reduced 25.1%	14,476 $903,000
Q3 2021 Nov 10, 2021	BUY	$59.17 - $69.31 $41,359 - $48,447	699 Added 3.75%	19,327 $1.14 Million
Q2 2021 Aug 10, 2021	SELL	$61.91 - $67.42 $15,229 - $16,585	-246 Reduced 1.3%	18,628 $1.25 Million

Q1 2021 May 10, 2021	BUY	$59.34 - $66.74 $1.12 Million - $1.26 Million	18,874 New	18,874 $1.19 Million

2,552

1.49B

25.9M

20M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $87.4B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Davidson Capital Management Inc., based on Form 13F filings with the SEC.

Stay updated on Davidson Capital Management Inc. with notifications on news.